Final Flashcards
list the five inner ear diseases
1) otosclerosis
2) meniere’s disease
3) autoimmune inner ear disease
4) sudden and idiopathic SNHL
5) vascular lesions
another name for otosclerosis
otospongiosis
epidemiology of otosclerosis (3 items)
- hereditary in 70% of cases
- –autosomal dominant/runs in families (50% of cases)
- –variable penetrance: have the disease but not the clinical symptoms
- more in females (2:1)
- –worsen during pregnancy/ estrogen therapy
- race dependent:
- –4-8% of caucasian-1% with symptoms
- –1% of black
when is the onset of otosclerosis?
11-30 years of age (70% of cases)
—develops in the third decade of life
how does the hearing loss with otosclerosis develop
- slowly progressive
- bilaterally, asymmetric conductive/mixed of even SNHL
- –unilateral in 10% of cases
otosclerosis pathogenesis theories (8)
- hereditary: autosomal dominant
- congenital=osteospongiosis
- –more immature bone: on and around the stapes footplate, otic capsule(cochlea/labyrinth)
- –excessive resorption of bone
- —-bone breakdown–new bone forms
- —-new bone is soft and hypervascular–a sclerotic mass
- developmental problems
- –embryology cartilage rests in otic capsule–abnormal bone
- trauma
- vascular problems
- –decrease blood supply–otosclerotic foci
- –acidity or perivascular tissue–decalcification–abnormal
- immunologic reactivity to collagen molecules: tests show high serum collagen level
- viral/measles-vaccination=less number of otosclerosis
- aging
- –changes in otic capsule=otosclerosis
- –vascular spaces are replaces by bone
- —-dense mosaic-patterned
involvement sites for osteospongiosis
- ant to oval window (90%)
- –anterior crus=root
- —-site of prevalence)
- –footplate fixation
- –annular ligament of stapes
*this leads to persistent CHL
osteospongiosis: how does it occur histologically?
focal fixation-diffuse active-quiescent-cochlear otosclerosis
other involvement sites for otospongeosis (6)
- promontory
- facial canal
- stapedial tendon
- incudostapedial joint
- vestibule and cochlear labyrinth=malignant otosclerosis
- round window niche=rare, profound loss
symptoms of otosclerosis
- hearin loss
- –bilateral, asymmetrical CHL depending on the degree of stapes fixation
- –unilateral in 10% of cases
- paracusis of willis (when limited to the stapes)
- –better hearing ability in noisy environment
- tinnitus (75%)
- –inner ear degenerative effects of the disease
- –varies in intensity and character
- vestibular disturbances-vertigo is rare (25%)
- –hydrops?
signs of otosclerosis
- in the otoscopic exam: schwartez sign= red descoloration under drum due to active focus on promontory
- tuning fork test: CHL
- PTA
- –unilateral or bilateral CHL
- –low freq (250-2000HZ)
- a slight SNHL at 2000Hz= carhart notch
- –associated SNHL: cochlear involvement
- WRS: excellent
carhart notch
- a sign of otosclerosis
- caused by stapedial fixation
- otosclerosis reduces BC thresholds by:
- –5dB at 500 HZ
- –10 at 1000
- –25 at 2000
- –15 at 4000
otosclerosis signs in audiometry (3)
1) initial stiffening of the stapediovestibular joint
- –low-freq tilt
- –slight ABG
2) footplate becomes fixed
- –friction elements added
- –flat configuration
- –ABG widens
3) cochlear lesion
- –high freq SNHL
- –drop in WRS
signs of otosclerosis in acoustic reflexes
- very sensitive
- “on-off” phenomenon
- precedes hearing loss
what types of imaging is used to see otosclerosis?
- CT
* MRI
differential diagnosis for otosclerosis
- congential footplate fixation
- tympanosclerosis
- incus/malleus fixation
- ossicular discontinuity
- systemic diseases:
- –osteogensis imperfecta
- –pagets disease
- –progressive bone disease of skull and long bone
osteogenesis imperfecta
- aka van der hoeve’s syndrome or brittle bone disease
- –stapes fixation
- –blue sclera
- –fractures-called fragillitas osseus
paget’s disease
osteitis deformans (3% of adults over 40 years)
progressive bone disease of skull and lone bone (skeletal bone)
- abnormal bone destruction and regrowth-deformity of the affected area
- temporal bone involvement= CHL 50%
- elevated alkaline phosphate
management of otosclerosis
- amplification
- –in early to moderate stage
- –refuse surgery
- –poor surgical candidate
- medial therapy
- stapes surgery
flouride as medical treatment for otosclerosis
- flourical:
- –sodium flouride, Ca carbonate, and vitamin D
- –food supplement and over the counter
- benefits
- –stabilizing bone
- –slow SNHL
- –statistical benefit is not equal to the clinical benefit
- side effects
- –uncommon
- –GI upset
- –musculoskeletal pain
goal of surgery for otosclerosis
- reconstruct sound conducting mechanism
- excellent results in >90% of cases on 6-8 weeks
- –10dB or less ABG
what can pts not do after surgery for otosclerosis?
valsalva
what would determine a successful otosclerosis surgery
10dB or less ABG
post op complications of stapedectomy
- postop vertigo is common (rest to treat)
- prothesis failure
- –30-82% of failures=displaced prosthesis
- –short prosthesis with fractures
- –floating footplate
- bleeding
- –mucosal trauma
- –active phase
- –persistent stapedial artery
- SNHL=0.2-10%
- –surgical trauma of drilling vs laser
- –serous labyrinthitis-high freqs
- –hydrop
- perilymph fistula
- –drop or fluctuation in hearing
- –tinnitus, vertigo
- —-re-explorationa nd sealing of the problem is a surgical emergency
- CSF gusher; causes:
- –congenital footplate fixation
- rare complications:
- –facial paralysis
- –acute otitis media
- –cholesteatoma
- rarely, a “dead ear” is the end result
pathogenesis of meniere’s disease
Temporal bone studies of membranous labyrinth show:
- dilation
- distortion
- membrane ruptures
sites:
- scala media
- saccule
causes of meniere’s disease
- poorly understood
- endolymphatic hydrops
- –increased pressure into the inner ear
- —-increased production
- —-increased resorption
- autoimmune etiology
- –response to immunotherapy=32% with anti68kDa antibody
- anatomic problems
why do the low frequencies become affected by meniere’s disease first
- the degree of endolymphatic space expansion is variable
- –50% of cases: bulged in the region of helicotrema
- saccule if bulged
- –against the footplate (60%)
- –into a horizontal SSC (1/3)
manifestations of meniere’s disease
- vertigo
- –episodic with normal intervals
- –lasts 20 min-12 hours
- –sudden episodes of fall (pts may think they had a stroke)
- low freq SNHL
- –fluctuating=10dB at 2 freq
- –progressive
- aural fullness
- roaring tinnitus
what are the types of meniere’s disease (and tell about them)
- definite MD
- –2 or more episodes of vertigo (20min-12hours)
- –low freq SNHL before, during, or after vertigo episodes
- –fluctuating aural manifestations (hearing, fullness, tinnitus)
- probable MD
- –2 or more episodes of vertigo (20min-24hours)
- –fluctuating aural manifestations
how is meniere’s disease diagnosed?
- otoscopy=norma;
- Hennebert’s sign in 30%
- –this is pressure induced vertigo and nystagmus
- puretone aud= cochlear HL
- ART, SISI, and ABLB
- ENG
- ECochG= enlarged SP-large SP/AP ratio
- ABR to rule out vestibular schwannoma
- Vestibular Evoked Myogenic Potential (VEMP)= test the integrity of the saccule portion of the inner ear and may detect meniere’s disease even when a patient is non-symptomatic
two diseases that must be differentiated from Meniere’s disease
- vestibular migraine (2%)
- –episodic vertigo (sec-days) and migraine headache, intolerance of head motion/motion sickness
- benign paroxysmal positional vertigo (BPPV)
what is another name for drop attacks
otolithic crises of tumarkin
causes of drop attacks and treatment
- cardiac disorders (64%)= medication or pacemakers
- seizures (7%)= anticonvulsant
- poor blood flow to brain (TIA) (8%)= lower cholesterol, blood thinners, surgery on arteries to open them up
- superior canal dehiscence (small%)= plug or patch superior canal
- meniere’s disease (5%)= surgery or medication to destroy labyrinth
nonsurgical treatment for meniere’s
- diet and vestibular suppression to reduce spells of vertigo
- –diet and salt restriction
- –valium during the episodes
- –diuretics: thiazides, neptazane
- –meniett device: small pressure pulses (3x daily/ 6 weeks)= displacement of excess endolymph=normal inner ear pressure
- steroids for the immune component (intratympanic or systemic)
- gentamicin perfusion (watch)= chemical vestibulectomy
- –gel foam soaked over the round window
- vestibular rehabilitation
surgical treatment for meniere’s
- endolymphatic sac decompression- less HL
- –endolymphatic subarachnoid shunt
- –endolymphatic-mastoid shunt
- vestibular nerve sectioning
- –retrosegmoid procedure (95% effective in controlling vertigo; less risk of HL)
- –translabyrinthine procedure= dead ear
- labyrinthectomy= destructive surgery= surgical ablation of end organ= cure vertigo
what % of cases of hearing loss or dizziness does autoimmune disease of the inner ear comprise
<1% of all cases of hearing loss or dizziness
what are the two immune principle
innate (nonspecific) response
adaptive (specific) response
the innate response of the immune specific
- first line of defense
- prevent micro-organism from entering body
- nonspecific
adaptive response of the immune system
- specific
- destroy invading organism
- –phagocytic cells= locally
- –humoral (B cell) and cellular (T) cell
- —-mediated systems hormones
- ——stimulate proliferation of
- —-T lymphocytes= immunoglobin
4 immune functions of the inner ear
- antigen-antibody reaction
- lymphocytes and immunoglobuling (Ig) production
- lymphatic drainage
- barriers
what is the antigen antibody process
the antigen stimulates lymphocytes which proliferate and mature into plasma cells which produce antibodies against one antigen
inner ear exposure to antigen
- primary exposure
- –localized immune response
- –beneath the basilar membrane of the basal coil of the cochlea
- 2ry (repeated) exposure
- –generalized immunologic response
- –all over the cochlea
- leads to degeneration of spiral ganglion cells, organ of corti, hemorrhage, etc
- antibodies are found in serum and perilymph as a result of immune response
how do lymphocytes and immunoglobulin (lg) production work as immune function of inner ear
- cochlea has no lymohocytes
- –antigens from inner ear migrate to endolymphatic sac which stimulates lymphocytes to produce antibodies
- systemic lymphocyte entry through spiral modiolar vein
- immune response decreased when endlymphatic sac (ELS) destroyed
lymphatic drainage as an immune function of the inner ear
- little lymphatic drainage leads to:
- limited immunosurveillance
- –perilymph has lgs (m,G,A,) at 1/1000th of serum concentration
- inner ear is subject to immune surveillance if:
- –systemic immunization led to inner ear immune response when antigen presented within inner ear
three types of barriers
- blood-labyrinthine barrier
- CSF-labyrinthine barrier
- middle ear-labyrinthine barrier
how do the barriers work
- protect the function of the inner ear from changes in the surrounding/extracellular fluids
- maintain ionic concentration of cochlear fluid
what are autoimmune inner ear diseases (AIED)
1) cogan’s disease
2) wegener’s ganulomatosis
3) secondary/other autoimmune disease
* Vogt-Koyanagi-Harada (VKH) syndrome
* Behcet’s disease
* relapsing polychondritis
* systemic lupus erythematosus
* rheumatoid arthritis
* polyarteritis Nodosa
theories of/pathogenesis of autoimmune SNHL
- vasculitis of inner ear
- autoantibodies (antigenic epitopes=antigenic determinant)
- –part of the antigen is recognized by the immune system (antibodies, B cells, or T-cells)
- cross-reacting antibodies
cogan’s disease definition
- rare
- systemic autoimmune disease of the cornea and inner ear
- –inflam reaction of temporal bone and membranous labyrinth=bilateral degeneration
- —-cochlea and vestibular labyrinth
- —-hydrops
etiology of cogan’s disease
- etiology is unknown
- –viral or microbial etiology
- –autoimmune disease
cogan’s disease signs and symptoms
- ocular and otologic (audiovestibular) symptoms
- otologic: similar to meniere’s
- –vertigo and HL
- ocular
- –nonsyphilitic interstitial keratitis (IK)
- —-blood vessels grow into the cornea
- —-loss of the normal clearness of the cornea
history and clinical manifestations of cogan’s disease
- middle aged women with onset 22-29 years
- –65% female, 35% male
- progressive SNHL, weeks to months
- dizziness, aural fullness
- one ear first then the other
- –bilateral 79%
- no acute vestibular symptoms-slow loss of vestibular function
how many with cogan’s disease are originally diagnosed with meniere’s?
1/4 to 1/2
clinical manifestations of cogan’s disease (typical vs atypical type)
- typical type:
- –audio-vestibular symptoms occur before or after IK
- —-sudden IK, photophobia, ocular pain, eye redness
- —-fluctuating and progressive SNHL, tinnitus, vertigo, and loss of vestibular function
- atypical type
- –audio-vestibular symptoms occur with ocular disease other than IK
- —-eg uveitis, iritis, scleritis, and conjuctivitis
- systemic autoimmune symptoms (29%)
- –vasculitis, arthritis rashes, auricular pain
- –GI hemorrhage, etc
cogan’s diagnosis
*clinically
*laboratory
—lymphocyte transformation test
(LTT)
—–93% specific
—–50-80% sensitive
—anti-68kDa protein
—–95% specific
—–insensitive
—–predictor of steroid response
—ESR
—CRP (along with ESR is acute phase)
—C1q binding assay
—anti-cardiolipin
—ANCA=anti-neutrophil cytoplasmic antibody
—syphilis testing
—lyme titers (endemic areas)
—CBC
—chemistries
—thyroid functions
—imaging
treatment of Cogan’s syndrome
- steroid
- –steroid eye drops
- –high-dose for hearing loss
- —-little effect if no measurable hearing before Rx
- untreated cases=profound bilateral SNHL over several months
- –cochlear implantation
what is wegener’s granulomatosis?
- necrotizing granulomata and vasculitis
- –respiratory tract
- –kidney’s-glomerulonephritis
- –blood vessels: vasculitis and ischemia
- —-inner ear= SNHL
- –serous OM (25%)
diagnosis of wegener’s granulamatosis
- antineutrophil cytoplasmic antibody (cANCA)
- –90% specific
- tissue biopsy
general definition of secondary/other autoimmune disease HL
- HL secondary to systemic autoimmune disease
- –lupus rheumatoid arthritis
Diagnosis for secondary/other autoimmune disease
- frequently inferred
* MRI: cochlear inflammation may be seen
treatment of secondary.other autoimmune disease
directed at primary disorder
again list the secondary/other autoimmune diseases (76
- vogt-koyanagi-harada (VKH) syndrome
- behcet’s disease
- relapsing polychindritis
- systemic lupus erythematosus
- rheumatoid arthritis
- polyarteritis nodosa
vogt-koyanago-harada (VKH) syndrome
- imflammatory disease: biateral panuveitis with involvement of the CNS, ear and skin
- autoimmunity to melanocytes
- –depigmentation=poliosis
- –periorbital hair loss
- –aseptic meningitis
- –SNHL, vesitbular signs, uveitis
bechet’s disease
*autoimmune disease
*affects: mucocutaneous, ocular, cardiovascular, renal, pulmonary, GSI, vascular, urology, musculoskeletal and CNS systems
*recurrent oral and genital ulcers
(aphthous ulers=cancer sore)
relapsing polychondritis
- recurrent inflam of
- –ear, nose, trachea, larynx
- –peripheral joints
- autoantibodies to cartilage type II and IX
- —-II: otic capsule and tectorial membrane
- diagnosis:
- –elevated ESR and Igs
- –positive LTT
- treatment
- –NSAIDs and steroids
systemic lupus erythematosus
- anti-nuclear, anti-DNA antibodies
- numerous systemic manifestations
- –polyarthralgia, arthritis
- –pleuritis, pericarditis, myocarditis
- –pneumonitis, nephritis
- –CN palsies, meningitis, neuritis
- –scleritis, renal degeneration from vasculitis
- COM with vasculitis
- progressive SNHL, dysequilibrium
- rash=rare
rheumatoid arthritis
- small joints of hands and feet
- vasculitis, muscle atrophy, subcutaneous, nodules, splenomegaly
- rheumatoid factors (75%)
- –lgM 19S and 7S, lgG 7S
- –reaction to abnormal lgG produced within the synovia
- CHL–ossicular joint fixation
- SNHL
- –cochlear inflammation
- –side effect of medications
polyarteritis nodosa
- vasculitis of small and medium-sized arteries
- renal and visceral
- ischemia=osteoneogenesis fibrosis
- –temporal bone studies
- hearing loss=rare
- –vasculitis
autoimmune disease treatment
- immunosuppressive agents
- –stabilize the progressive hearing loss
- –steroids
- —-systemic
- —-transtympanic: less commonly used
- ——-less toxic
- ——-efficacy unproven
- –methotrexate: helpful= reduce steroid dose
- –cyclophosphamide (CTX) + prednisone:
- —-discontinue CTX after 3 months
- —-continue with prednisone for another 2 wks, then gradual withdrawal
- avoid early withdrawal:
- –2ry immune response is ore robust than the 1ry immune response
long-term steroid treatment: contraindication
- preganacy
- peptic ulcer
- hypertension, DM
- glaucoma
- TB
- recent vaccination
long-term steroid treatment: side-effects
- GI reactions
- edema
- osteoporosis
- CNS disorders
- –euphoria
- –mood swings
- –insomnia
steriod treatment alternative
- plasmapheresis
- circulating antigens, immune complexes, and inflammatory mediators are removed from plasma
- –improvement in 50-75% of cases
- indications
- –when SNHL shows initial response with subsequent failure
- –when steroids are contraindicated
sudden sensorineural hearing loss (SSNHL)
definition and time course
- 30 dB or greater SNHL
- over at lease 3 adjacent frequencies
- occurring within 3 days or less
- devastating to pts
- frustrating for physicians
- definitive diagnosis and treatment unknown
- –90% of cases are idiopathic
SSNHL statistics
- 4000 cases/year in the US
- –b/t one and 6 people per 5000 every year
- 15000 reported cases/year worldwide
- highest incidence in 50-60 years old
- lowest incidence in 20-30 year olds
- men= women
- 2% bilateral
Causes of SSNHL
- symptoms of URT infections (infections)
- H/O ototoxic drug use (medicatons)
- H/O head trauma, straining, sneezing, nose blowing, intense noise exposure
- H/O flying or scuba diving (trauma)
associated symptoms of SSNHL
- vertigo/dizziness
- aural fullness
- tinnitus
additional things to look for in history w/ SSNHL
- past medical history:
- –autoimmune disorders
- –vascular disease
- –malignancies
- –neurologic conditions
- –hypercoagulable states
- —-sickle cell disease (African Americans)
- past surgical history:
- –stapedectomy or
- –other otologic surgeries
physcial exam for SSNHL
- complete head and neck exam in everyone
- neurologic exam of sensory and motor systems
- –tandem gait (cerebellar vermis)= toes of the back foot touch the heel of the front feet with each step
- –Rombers=a test of proprioception= stand feet together with eyes open the closed
- –nose to finger or heel to shin
- vestibular= Dix-Halpike test
diagnostic testing for SSNHL
- audiologic eval:
- –pure tone audiometry
- –speech discrimination
- –tympanometry
- –stapedial reflex
- lab testing
- –CBC, ESR, VDRL
- –lymphocyte transformation test (LTT)
- –western blot for antibodies to 68 KD protein
- MRI
- –CPA tumors
- —-13% of pts with acoustic tumors present with SSNHL
- —-13% may recover hearing
- –multiple sclerosis
- –ischemic changes
treatable causes of SSNHL
- infections
- autoimmune
- vascular
- traumatic
- neoplastic
- idiopathic SSNHL (I-SSNHL)
- –viral infections
- –autoimmune
- –vascular compromise
SSNHL from Viral labyrinthitis (what causes it and why does it occur)
- causes: URI viruses, measles, mumps, chicken pox, and herpes zoster
- pathology can vary
- –damage to cochlea and vestibular labyrinth
symptoms of SSNHL from viral labyrinthitis
- symptoms may vary
- –SNHL, tinnitus, and vertigo
- –if only vertigo without hearing loss
- —-the diagnosis is likely vestibular neuronitis
- —labyrinthine concussion
SSNHL from trauma
1) acoustic: NIHL
2) barotrauma: visceral rupture
3) perilymphatic fistula
4) rupture of membranous labyrinth